ReviewInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society2023

The promise of combining CDK4/6 inhibition with hormonal therapy in the first-line treatment setting for metastatic or recurrent endometrial adenocarcinoma.

Isabelle Ray-Coquard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.